Revolutionizing Musculoskeletal Care: Livara Health's $15M Funding Boost
May 7, 2024, 9:32 am
Livara Health, a pioneer in value-based musculoskeletal (MSK) management, recently secured a $15 million Series B funding round, bringing their total funding to $27 million. The company's innovative approach aims to transform the traditional siloed care model in MSK treatment, providing a comprehensive, end-to-end solution for patients in pain.
Livara Health, formerly known as SpineZone, recognizes the fragmented nature of musculoskeletal care, where patients often navigate through various providers without a cohesive care plan. CEO Rob Cohen highlights the gaps in psychosocial support, such as mindfulness, nutrition, and sleep habits, that often go unaddressed during the treatment journey.
The company's solution is to bridge these gaps by partnering with risk-bearing providers and payers to sub-capitate the MSK spend and deliver personalized care plans for patients. By identifying members at risk of MSK issues and providing early intervention, Livara aims to reduce unnecessary surgeries and imaging procedures, ultimately improving outcomes and lowering costs.
With a focus on value-based MSK management, Livara has treated over 120,000 individuals and boasts nearly 4 million eligible members in 2024. Their data-driven approach has shown significant results, with a 54% reduction in surgeries and a 49% decrease in imaging costs among Medicare Advantage patients in Southern California.
Unlike other players in the MSK space, Livara stands out for its multidisciplinary approach, combining virtual and in-person care, psychosocial interventions, and expert coaching for a holistic treatment experience. The company's clinical model, refined over 17 years of experience, emphasizes accurate assessment, diagnosis, and personalized care planning for each patient.
The recent funding round, led by A1 Health Ventures and supported by existing investors, will fuel Livara's growth initiatives, including expanding their leadership team, enhancing technology and clinical capabilities, and scaling their innovative care model. CEO Rob Cohen envisions a future where Livara continues to impact individuals' lives, drive positive outcomes, and expand their reach to more payers and providers.
Livara Health's commitment to revolutionizing musculoskeletal care through value-based solutions sets them apart in the healthcare landscape. With a focus on patient-centric, outcomes-driven care, the company is poised to make a lasting impact on the MSK space and empower individuals to thrive in their pursuit of health and wellness.
Livara Health, formerly known as SpineZone, recognizes the fragmented nature of musculoskeletal care, where patients often navigate through various providers without a cohesive care plan. CEO Rob Cohen highlights the gaps in psychosocial support, such as mindfulness, nutrition, and sleep habits, that often go unaddressed during the treatment journey.
The company's solution is to bridge these gaps by partnering with risk-bearing providers and payers to sub-capitate the MSK spend and deliver personalized care plans for patients. By identifying members at risk of MSK issues and providing early intervention, Livara aims to reduce unnecessary surgeries and imaging procedures, ultimately improving outcomes and lowering costs.
With a focus on value-based MSK management, Livara has treated over 120,000 individuals and boasts nearly 4 million eligible members in 2024. Their data-driven approach has shown significant results, with a 54% reduction in surgeries and a 49% decrease in imaging costs among Medicare Advantage patients in Southern California.
Unlike other players in the MSK space, Livara stands out for its multidisciplinary approach, combining virtual and in-person care, psychosocial interventions, and expert coaching for a holistic treatment experience. The company's clinical model, refined over 17 years of experience, emphasizes accurate assessment, diagnosis, and personalized care planning for each patient.
The recent funding round, led by A1 Health Ventures and supported by existing investors, will fuel Livara's growth initiatives, including expanding their leadership team, enhancing technology and clinical capabilities, and scaling their innovative care model. CEO Rob Cohen envisions a future where Livara continues to impact individuals' lives, drive positive outcomes, and expand their reach to more payers and providers.
Livara Health's commitment to revolutionizing musculoskeletal care through value-based solutions sets them apart in the healthcare landscape. With a focus on patient-centric, outcomes-driven care, the company is poised to make a lasting impact on the MSK space and empower individuals to thrive in their pursuit of health and wellness.